Market revenue in 2023 | USD 3,264.8 million |
Market revenue in 2030 | USD 8,952.4 million |
Growth rate | 15.5% (CAGR from 2023 to 2030) |
Largest segment | Oocytes |
Fastest growing segment | Sperm |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Oocytes, Embryo, Sperm |
Key market players worldwide | Vitrolife AB ADR, Genea Biomedx, Immersion Corp, The Cooper Companies Inc, FUJIFILM Holdings Corp, BioTech Medics Inc, Nidacon, Minitube, Kitazato, VitaVitro Biotech |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to vitrification market will help companies and investors design strategic landscapes.
Oocytes was the largest segment with a revenue share of 41.93% in 2024. Horizon Databook has segmented the Europe vitrification market based on oocytes, embryo, sperm covering the revenue growth of each sub-segment from 2018 to 2030.
Europe accounts for a considerable revenue share of the vitrification market due to the presence of developed economies, such as Germany, Spain, the UK, France, and Italy. These countries have advanced infrastructure, which is anticipated to significantly boost cryopreservation modalities in the region.
Moreover, the market growth can be attributed to a growing biotechnology industry and rising investments in developing assisted reproduction technologies in countries such as the UK & Germany. In nearly all European countries, ART is controlled by legislation with few variations in the details of the framework between countries.
In the case of egg and sperm freezing by vitrification for medical reasons such as cancer, there is no specific legislation that prohibits the use of this technique. Thus, biospecimen preservation for medical reasons is allowed in nearly all European countries.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe vitrification market , including forecasts for subscribers. This continent databook contains high-level insights into Europe vitrification market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account